Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive: a Multicenter Trial
This Study is
No Longer Enrolling
1. Women who desire a COC for contraception will be willing to initiate and continue an ENG implant as a continuous back-up method. 2. Women using a COC concomitantly with ENG implant will have low rates (<5%) of ENG discontinuation for bleeding complaints. 3. A high percentage of women in the study will still be using the ENG implant after 52 weeks (1 year).
MoreAdult
Women 18 years and older currently using COCs or who have a COC prescription and are intending to initiate COCs for contraception Exclusion Criteria. Women who have contraindications to using a COC or a contraceptive implant (Category 3 or 4 in the CDC Medical Eligibility Criteria [MEC]) o Because the CDC MEC are continuously revised, we will refer to the most updated criteria at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5904a3.htm Women who are currently participating in a clinical trial or have participated within the past 30 days. Less than 2 weeks from the end of a pregnancy.
Women 18 years and older currently using COCs or who have a COC prescription and are intending to initiate COCs for contraception Exclusion Criteria. Women who have contraindications to using a COC or a contraceptive implant (Category 3 or 4 in the CDC Medical Eligibility Criteria [MEC]) o Because the CDC MEC are continuously revised, we will refer to the most updated criteria at http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5904a3.htm Women who are currently participating in a clinical trial or have participated within the past 30 days. Less than 2 weeks from the end of a pregnancy.
Device Feasibility
Comprehensive Women's Health Center
Protocol Number: 20-1945
More information available at ClinicalTrials.gov: NCT04423055
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers